Brain MRI: Clinical Trials

5 trials of Brain MRI, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5
Phase 12Completed 2

Follow Brain MRI: new trials by email Literature Review of Brain MRI trials Research Report on Brain MRI

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).
Bintrafusp alfa/M7824, Ibuprofen, PET scan - Olfactory Neuroblastoma, Esthesioneuroblastoma
Phase 2CompletedNational Cancer Institute (NCI)112022-06-212025-08-08
HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers
PRGN-2009, M7824, EKG - HPV Positive Cancer, Vulvar, Vaginal, Penile, Rectal Cancer
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)392020-08-112026-08-18
Administration of Methionine in Patients With Pulmonary Alveolar Proteinosis by Mutation of the MARS Gene.
Methionine, Vitamin B12, B9, B6, C supplementation, Methionine/homocysteine Dosage - Pulmonary Alveolar Proteinosis, Mutation Ala393Thr of the MARS Gene
Phase 1 / Phase 2CompletedAssistance Publique - Hôpitaux de Paris32019-09-162025-11-20
Monocentric Pilot Study, for a Randomized, Crossover, Blinded Trial: Comparison of the Therapeutic Efficacy of Low Frequency Repeated Transcranial Magnetic Stimulation on Cortical Area 9 Compared to Brodmann Area 46 in the Treatment of Depressive Disorders.
rTMS BA9/BA46, rTMS BA46/BA9, brain MRI - Patients With Resistant Depressive Disorders
Phase 2CompletedCentre Hospitalier Universitaire Dijon172010-02-012018-09-04
Treatment and Natural History Study of Lymphomatoid Granulomatosis
Interferon, Rituxan and EPOCH, Tumor biopsy - Lymphomatoid Granulomatosis, Granulomatosis, Lymphomatoid
Phase 2CompletedNational Cancer Institute (NCI)941995-05-052025-06-19

Conditions studied

Anus Neoplasms (1)  ·  Epstein-Barr Virus Infections (1)  ·  Esthesioneuroblastoma, Olfactory (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphomatoid Granulomatosis (1)  ·  Lymphoproliferative Disorders (1)  ·  Nose Neoplasms (1)  ·  Oropharyngeal Neoplasms (1)  ·  Pulmonary Alveolar Proteinosis (1)  ·  Rectal Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)

Sponsors

National Cancer Institute (NCI) (3)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Centre Hospitalier Universitaire Dijon (1)

Countries

United States (3)  ·  France (2)

Top investigators

Charalampos Floudas, M.D. (2)  ·  Christopher J Melani, M.D. (1)

Results publications

PMID 34503986, PMID 37011643, PMID 39500789, PMID 40116923, PMID 42307670

NIH funding

2018 (1)